Girls in Transition Study: Helping Girls Enter the Teenage Years (GT)
|ClinicalTrials.gov Identifier: NCT00641940|
Recruitment Status : Unknown
Verified March 2008 by Swarthmore College.
Recruitment status was: Active, not recruiting
First Posted : March 24, 2008
Last Update Posted : March 24, 2008
|Condition or disease||Intervention/treatment||Phase|
|Depression Anxiety||Behavioral: Girls in Transition (GT) program Behavioral: Waitlist Control||Phase 1|
Gender differences in rates of depression emerge during adolescence. Although rates of depression increase for both boys and girls during adolescence, the increase is more dramatic for girls. By late adolescence, girls are twice as likely as boys to develop depression. Because the transition to adolescence has been identified as a period of increased risk for girls, preventive interventions targeting early adolescent girls may promote resilience and prevent depression. The Girls in Transition (GT) program is a group intervention for 6th through 8th grade girls and is designed to address risk factors that are specific to girls. This study evaluates the effectiveness of the GT intervention in promoting coping strategies, preventing symptoms of depression and anxiety, and providing benefits in other outcomes related to depression, such as self-image.
Adolescents in this study will be assigned to one of two conditions: a group that will participate in the GT program in Spring 2006 (GT #1), or a waitlist control group that will participate in the GT program approximately two years later (GT #2). Students who participate in the program will attend eleven 90-minute after-school sessions led by the investigators. In the GT program, students learn cognitive-behavioral skills (such as strategies to cope with emotions and negative thinking) and problem-solving skills (such as assertiveness), and they discuss societal messages about women's appearance and roles. Adolescent participants will complete questionnaires about coping strategies, self-image, and feelings of hopelessness, depression and anxiety at five points during the study: at the beginning of the study (baseline) and at follow-ups approximately 6, 12, 16, and 24 months after baseline. In addition, students will complete an interview at baseline and then again 12 months later about experiences in which they have coped with stressful situations. Parents will complete a questionnaire about their child's life events at three assessment points (baseline and at follow-ups approximately 12 and 24 months after baseline).
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||32 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Girls in Transition Study: Helping Girls Enter the Teenage Years|
|Study Start Date :||October 2005|
|Estimated Primary Completion Date :||June 2008|
|Estimated Study Completion Date :||June 2008|
Girls in Transition (GT) program
Behavioral: Girls in Transition (GT) program
In the 11-session after-school GT program, girls learn cognitive and behavioral skills related to intrapersonal, interpersonal, and social/contextual risk factors for depression.
Other Name: GT #1
Behavioral: Waitlist Control
Participants in the waitlist control group will complete the GT program during the third year of the study.
Other Name: GT #2
- Adolescents' coping strategies by self-report [ Time Frame: Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline ]
- Adolescents' depressive symptoms by self-report [ Time Frame: Measured at baseline and follow-ups approximately 6, 12, 16, and 24 months after baseline ]
- Adolescents' symptoms of anxiety by self-report [ Time Frame: Measured at baseline and follow-ups approximately 6, 12, 16, and 24 months after baseline ]
- Adolescents' feelings of hopelessness by self-report [ Time Frame: Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline ]
- Adolescents' perceptions of their physical appearance by self-report [ Time Frame: Measured at baseline and follow-ups approximately 6, 12, and 24 months after baseline ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00641940
|United States, Pennsylvania|
|Swarthmore, Pennsylvania, United States, 19081|
|Principal Investigator:||Jane E. Gillham, Ph.D.||Swarthmore College|